Gentle vibration tested to fight cancer Drug's aches and fatigue
NCT ID NCT03712813
Summary
This study tested whether a gentle, low-intensity vibration platform could help reduce muscle and joint pain, fatigue, and weakness caused by a common breast cancer medication (aromatase inhibitors). For 12 months, 72 early-stage breast cancer survivors either used the vibration platform for 10 minutes twice daily or were placed on a waitlist. Researchers measured changes in muscle strength, body composition, bone density, and participants' reports of pain and fatigue.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Indiana University Melvin & Bren Simon Cancer Center
Indianapolis, Indiana, 46202, United States
Conditions
Explore the condition pages connected to this study.